A 76-year old female patient presented at the Emergency Room (ER) because of acute respiratory distress. She was known with an Ischemic Cerebrovascular Accident (CVA -2018) and a severe aortic valve stenosis (AS -AVA 0.6 cm²). Her cardiovascular risk factors included past smoker, insulin-dependent diabetes and hypercholesterolemia. On her initial presentation at the ER, she showed signs of shock with hypotension (BP 85/55 mmHg), tachycardia and even desaturation (84%).
Bedside transthoracic echocardiography (TTE) showed severely depressed left ventricle function (visual estimation about 15%) as a result of diffuse hypokinesia and apical and lateral akinesia and the known underlying severe AS.
Diagnosis of cardiogenic shock with acute pulmonary oedema due to Non-ST Elevation Myocardial Infarction (NSTEMI) and underlying severe AS was made and the patient was admitted to the Cardiac Care Unit (CCU). Therapy with Bilevel Positive Airway Pressure (BIPAP) and diuretics was initiated. Because of respiratory deterioration, the patient was intubated and ventilated. The medical status of the patient further declined with renal failure, anuria, metabolic disorders with hyperkalemia and ongoing pulmonary oedema. Therefore, Continuous Venovenous Hemofiltration (CVVH) was started. Despite all this and support with vasopressors and inotropics, further decline of her cardiac function and overall condition occurred. The decision for transfer to the cathlab was made. In the assumption that her severe AS was the main trigger of her medical decline, an urgent Percutaneous Transluminal Aortic Valvuloplasty (PTAV) was performed with one successful inflation of a 20 mm Tyshak balloon (Numed, US) ( Fig 2) without right ventricle pacing. Reduction of the transvalvular gradient was obtained from 30 mmHg (during shock) to 5 mmHg.
Secondly, coronary angiography was performed. The right coronary artery (RCA) and left anterior descendens (LAD) were free from significant lesions (Fig 3) , but the dominant circumflex (Cx) showed a severe stenosis of the proximal segment which was treated with one drug eluting stent (3.0 x 16 mm Cre8 Evo 3, Alvimedica, Italy) (Fig 4) .
